Skip to main content
. 2022 Dec 5;32(Suppl 12):S76–S83. doi: 10.2188/jea.JE20210165

Table 1. Sample characteristics.

  D12 D23 D13
Sex Men 121,551 (50.2%) 93,758 (50.2%) 5,356 (50.5%)
Women 120,352 (49.8%) 93,064 (49.8%) 5,243 (49.5%)
 
Age, years 0–4 9,696 (4.0%) 0 (0.0%) 0 (0.0%)
5–9 67,459 (27.9%) 42,945 (23.0%) 4,504 (42.5%)
10–14 86,020 (35.6%) 75,780 (40.6%) 1,670 (15.8%)
15–19 64,888 (26.8%) 59,075 (31.6%) 2,542 (24.0%)
20–24 13,836 (5.7%) 8,224 (4.4%) 1,607 (15.2%)
25–27 4 (0.0%) 798 (0.4%) 276 (2.6%)
 
BMI, kg/m2 5 to <15 31,189 (12.9%) 18,304 (9.8%) 1,659 (15.7%)
15 to <20 134,620 (55.7%) 103,149 (55.2%) 5,442 (51.3%)
20 to <25 63,950 (26.4%) 55,013 (29.4%) 2,815 (26.6%)
25 to <30 9,635 (4.0%) 8,281 (4.4%) 500 (4.7%)
30 to <50 2,509 (1.0%) 2,075 (1.1%) 183 (1.7%)
 
Interval, years Minimum 0.019   0.071   1.159  
1st Quantile 1.986   1.841   3.663  
Median 2.088   2.005   4.049  
Mean 2.126   2.031   4.025  
3rd Quantile 2.252   2.197   4.397  
Maximum 6.562   5.608   8.211  
 
Number of diagnosed
thyroid cancer
69   28   2  
Total 241,903   186,822   10,599  

Dxy, the subgroup that underwent thyroid screening examination at the xth and yth round surveys.